PREDICTORS OF SERIOUS INFECTIONS IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING TARGET THERAPY.

被引：0
|
作者：
Koltsova, E. [1 ,2 ]
Lukina, G. [2 ,3 ]
Shmidt, E. [4 ]
Lytkina, K. [5 ]
Zhilyaev, E. [6 ,7 ]
机构：
[1] Org Hlth & Healthcare Management, Res Inst, Moscow, Russia
[2] AS Loginov Moscow Clin Sci Ctr, Moscow, Russia
[3] VA Nasonova Res Inst Rheumatol, Moscow, Russia
[4] NI Pirogov City Clin Hosp, Moscow, Russia
[5] City Clin Hosp, Moscow, Russia
[6] European Med Ctr, Moscow, Russia
[7] Minist Healthcare Russian Federat, Russian Med Acad Continuous Profess Educ, Moscow, Russia
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2020年 / 79卷
关键词：
D O I：
10.1136/annrheumdis-2020-eular.6227
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0303
引用
收藏
页码：1447 / 1447
页数：1
相关论文
共 50 条
  • [21] Trends in Serious Infections in Rheumatoid Arthritis
    Mhuircheartaigh, Or La M. Ni
    Matteson, Eric L.
    Green, Abigail B.
    Crowson, Cynthia S.
    JOURNAL OF RHEUMATOLOGY, 2013, 40 (05) : 611 - 616
  • [22] Serious infections with tocilizumab in rheumatoid arthritis
    Reactions Weekly, 2019, 1739 (1) : 13 - 13
  • [23] The Risk Of Serious Infections In Patients Receiving Rituximab For Rheumatoid Arthritis: Results From The British Society For Rheumatology Biologics Register-Rheumatoid Arthritis
    Silva-Fernandez, Lucia
    Lunt, Mark
    Low, Audrey S.
    Watson, Kath D.
    Symmons, Deborah P.
    Hyrich, Kimme L.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S341 - S341
  • [24] Serious infections and their predictors in a Swiss cohort of rheumatoid arthritis (RA) patients treated with TNF inhibitors.
    Forster, A
    Gasser, LH
    Daneel, S
    Dudler, J
    Stingelin, S
    Oertle, S
    Tyndall, A
    Michel, BA
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S328 - S328
  • [25] Multiple morbidities are associated with serious infections in patients with rheumatoid arthritis
    Kimbrough, Bradly A.
    Crowson, Cynthia S.
    Lennon, Ryan J.
    Davis III, John M.
    Strangfeld, Anja
    Myasoedova, Elena
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2024, 65
  • [26] INFECTIONS AND SERIOUS INFECTIONS IN THE FILGOTINIB RHEUMATOID ARTHRITIS PROGRAM
    Galloway, J.
    Buch, M. H.
    Yamaoka, K.
    Leatherwood, C.
    Pechonkina, A.
    Tiamiyu, I.
    Jiang, D.
    Ye, L.
    Besuyen, R.
    Aletaha, D.
    Winthrop, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 70 - 71
  • [27] Opioid Analgesics and the Risk of Serious Infections among Patients with Rheumatoid Arthritis
    Wiese, Andrew D.
    Griffin, Marie R.
    Stein, C. Michael
    Mitchell, Edward F., Jr.
    Grijalva, Carlos G.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 232 - 233
  • [28] Incidence of serious respiratory infections in patients with rheumatoid arthritis treated with tocilizumab
    Hoshi, Daisuke
    Nakajima, Ayako
    Inoue, Eisuke
    Shidara, Kumi
    Sato, Eri
    Kitahama, Mariko
    Seto, Yohei
    Tanaka, Eiichi
    Urano, Wako
    Ichikawa, Naomi
    Koseki, Yumi
    Momohara, Shigeki
    Taniguchi, Astuo
    Nishimoto, Norihiro
    Yamanaka, Hisashi
    MODERN RHEUMATOLOGY, 2012, 22 (01) : 122 - 127
  • [29] CASE DEFINITION OF SERIOUS INFECTION AFFECTS INCIDENCE AND PREDICTORS IN AN INCEPTION COHORT OF RHEUMATOID ARTHRITIS PATIENTS RECEIVING ANTI-TUMOR NECROSIS FACTOR THERAPY
    Homik, J.
    Thanh, N.
    Ohinmaa, A.
    Barnabe, C.
    Martin, L.
    Barr, S.
    Maksymowych, W.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 628 - 629
  • [30] The risk of serious infections in patients receiving anakinra for rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register
    Galloway, James B.
    Hyrich, Kimme L.
    Mercer, Louise K.
    Dixon, William G.
    Watson, Kath D.
    Lunt, Mark
    Symmons, Deborah P. M.
    RHEUMATOLOGY, 2011, 50 (07) : 1341 - 1342
12345